CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma
Cancer Research, 07/17/2012
Gao Q et al. – The results support the concept that inhibition of the CXCR6–CXCL16 pathway may improve prognosis after hepatocellular carcinoma (HCC) treatment.



